M 177 (Divalproex Sodium Extended-Release 250 mg)

Pill with imprint M 177 is White, Round and has been identified as Divalproex Sodium Extended-Release 250 mg. It is supplied by Mylan Pharmaceuticals Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M 177

Divalproex Sodium Extended-Release

Imprint:

M 177

Strength:

250 mg

Color:

White

Size:

12.00 mm

Shape:

Round

Availability:

Prescription only

Drug Class:

Fatty acid derivative anticonvulsants

Pregnancy Category:

D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder
X - Not for use in pregnancy - When treating migraine

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Mylan Pharmaceuticals Inc.

Inactive Ingredients:

• ammonia
• silicon dioxide
• dibutyl sebacate
• oleic acid
• polydextrose
• microcrystalline cellulose
• titanium dioxide
• triacetin

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC Code	Labeler / Repackager
00378-0472	Mylan Pharmaceuticals Inc.
51079-0766	UDL Laboratories Inc.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer